Navigation Links
Regeneron Reports Full Year and Fourth Quarter 2010 Financial and Operating Results
Date:2/17/2011

TARRYTOWN, N.Y., Feb. 17, 2011 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced financial results for the full year and fourth quarter of 2010 and provided an update on development programs and upcoming milestones.  

"2010 was a very productive year for Regeneron as we reported positive Phase 3 results in four clinical trials: two with VEGF Trap-Eye in wet age-related macular degeneration, called wet AMD, one with VEGF Trap-Eye in central retinal vein occlusion, and one with ARCALYST® for the prevention of gout flares in patients initiating uric-acid lowering therapy," said Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron.  "We expect regulatory applications to be filed in the first half of 2011 for marketing approval in the U.S. and Europe for VEGF Trap-Eye in wet AMD.  We also look forward to reporting results from additional Phase 3 trials in central retinal vein occlusion and gout and from two Phase 3 trials with aflibercept in cancer."

"In anticipation of potential product approvals," Dr. Schleifer added, "we are continuing to build our commercialization capabilities.  We are also advancing our earlier-stage pipeline which currently includes eight fully-human monoclonal antibodies in clinical development for the treatment of various diseases and conditions including elevated LDL cholesterol, rheumatoid arthritis, atopic dermatitis, and cancer.  We anticipate Phase 2 data from some of these programs in 2011."

"We entered 2011 in a strong financial position to support our development and commercialization activities," commented Murray A. Goldberg, Chief Financial Officer, "with approximately $627 million in cash and securities, following a successful public offering of Common Stock in October 2010."

Clinical Programs UpdateVEGF Trap-Eye (aflibercept opht
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
2. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
3. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
4. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
5. Regeneron Reports Third Quarter 2009 Financial and Operating Results
6. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
7. Regeneron Announces Presentation at the Deutsche Bank 2009 Biotech Boston Confab
8. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
9. Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Conference
10. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
11. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 2014 Blue Bell, Pennsylvania will ... a leading global Contract Research Organization (CRO), is relocating employees from ... locations into new modern Class A+ office space in ... week and marks the first phase of the relocation plan. ... said Harris Koffer , President of the Strategic Solutions Group ...
(Date:8/26/2014)... 2014 Biomedical Research Laboratories (BRL) ( www.brlscience.com ... the prestigious 2014 Inc. 500 list of America,s fastest-growing ... on this prestigious list and ranked among the most ... Biomedical Research Laboratories, CEO. "Today,s announcement represents a major ... the hard work and talent of our team. BRL ...
(Date:8/26/2014)... , Aug. 26, 2014 ... of the "Global Veterinary Diagnostics Market 2014-2018" ... Veterinary diagnostics include various tests, which are used ... livestock producers, and biomedical researchers are mainly availing ... testing (Deoxyribonucleic Acid/Ribonucleic Acid testing), immunodiagnostics, clinical chemistry, ...
Breaking Medicine Technology:PRA Health Sciences Expands in Pennsylvania 2Biomedical Research Laboratories Named to Inc. 500 List of America's Fastest-Growing Companies 2Global Veterinary Diagnostics Market 2014-2018: Key Vendors are Abaxis, Heska, IDEXX Laboratories, Mindray Medical, VCA Antech and Zoetis 2Global Veterinary Diagnostics Market 2014-2018: Key Vendors are Abaxis, Heska, IDEXX Laboratories, Mindray Medical, VCA Antech and Zoetis 3
... LAS VEGAS, May 22 CardioVascular,BioTherapeutics, Inc. (OTC Bulletin ... Christopher Moore to be the sponsor and general,partner of ... of,$1 million and up to $10 million of the ... am extremely impressed with CVBT,s wound healing drug, which ...
... Novavax, Inc. (Nasdaq:,NVAX) today announced that it ... vaccine candidate against Severe Acute Respiratory Syndrome,(SARS). The ... Institutes of Health (NIH) to continue preclinical development ... "Until now, it has been difficult to ...
Cached Medicine Technology:Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 2Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 3Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development 2Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development 3
(Date:8/27/2014)... August 27, 2014 In My Solitude, a ... Collection” to provide a growing number of women from college ... for goal setting and relaxing at the same time. , ... uses scent memory and visualization to help women stay focused ... each time they light a candle and enjoy the fragrance. ...
(Date:8/27/2014)... 2014 Michael A. Bottar ... of The Best Lawyers In America© for the practice ... Injury Litigation - Plaintiffs." , Bottar received his undergraduate ... laude graduate of Syracuse University College of Law where ... Practice" chapter of the Syracuse Law Review Survey of ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 iHire ... practices as the “Most Creative Workplace” in Frederick, ... Best Places to Work Awards. , Held at ... event is a joint partnership between the Frederick ... Economic Development, Frederick County Business Development and Retention, ...
(Date:8/27/2014)... *To find out more about this ... Research on the web ( http://www.achieveclinical.com ) or contact them ... There is no cost to participate , ... Compensation may be provided for time and travel ... there are at least 5 million Americans living with fibromyalgia. ...
(Date:8/26/2014)... BambooIndustry.com, the popular online supplier of bamboo products, has ... for the online market. Along with that, the company ... items are offered at greatly discounted prices, from 15 ... on September 10, 2014. , At present, all ... shipping costs. The company wants to offer an excellent ...
Breaking Medicine News(10 mins):Health News:In My Solitude Unveils Eco Candle Line That May Improve Performance 2Health News:Michael A. Bottar Selected For Inclusion In The Best Lawyers In America© 2015 2Health News:iHire Named Most Creative Workplace in Frederick, MD 2Health News:Achieve Clinical Research Is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial in Birmingham, Alabama 2Health News:Achieve Clinical Research Is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial in Birmingham, Alabama 3Health News:Discounted, High Quality Bamboo Floorings Provided Online By BambooIndustry.com 2
... 10 Nutraceutical International Corporation (Nasdaq: NUTR ) today reported ... 30, 2009. Net sales for the fiscal 2009 fourth quarter ... of fiscal 2008. For the fourth quarter of fiscal 2009, ... compared to net income of $1.5 million, or $0.14 diluted earnings ...
... ... all women using the birth control pills Yaz or Yasmin that they may ... vein thrombosis and other significant side effects as a result of the defective ... and Yasmin —known as drospirenone, or DRSP—has been linked to an increased risk ...
... Given the rising ... be offering free testing for Chlamydia at all six affiliated campuses in the State of ... Research Officer of the Institute in a meeting with health care providers in Polk county ... (Vocus) December 10, ...
... pcRUSH.com ... technology hardware to the various Branches of the United States Federal, State/Local Governments and ... , ... (PRWEB) December 10, 2009 -- pcRUSH.com / Atman, Inc. was recently awarded a General ...
... ... Machine Tool Giveaway contest. The 5 were chosen from a pool of nearly 400 ... accepted in video or essay form. , ... Charlotte, NC (PRWEB) December 10, 2009 -- Okuma America Corporation has announced the ...
... new study to asses patient awareness of medications prescribed during ... a medication they were not, and 96% were unable to ... had been prescribed during hospitalization. These findings are published ... Inpatient medication errors represent an important patient safety issue, with ...
Cached Medicine News:Health News:Nutraceutical Reports Fiscal 2009 Year End Results 2Health News:Nutraceutical Reports Fiscal 2009 Year End Results 3Health News:Nutraceutical Reports Fiscal 2009 Year End Results 4Health News:Nutraceutical Reports Fiscal 2009 Year End Results 5Health News:Nutraceutical Reports Fiscal 2009 Year End Results 6Health News:Nutraceutical Reports Fiscal 2009 Year End Results 7Health News:Nutraceutical Reports Fiscal 2009 Year End Results 8Health News:Hissey Kientz, LLP Warns Birth Control Pill Users Of Increased Health Risks To Those Who Have Or Are Taking YAZ or YASMIN 2Health News:Hissey Kientz, LLP Warns Birth Control Pill Users Of Increased Health Risks To Those Who Have Or Are Taking YAZ or YASMIN 3Health News:Hissey Kientz, LLP Warns Birth Control Pill Users Of Increased Health Risks To Those Who Have Or Are Taking YAZ or YASMIN 4Health News:The Institute of Women's Health of North America to Offer Free Chlamydia Testing at All Affiliated Campuses – Dr. Abdul Rao 2Health News:The Institute of Women's Health of North America to Offer Free Chlamydia Testing at All Affiliated Campuses – Dr. Abdul Rao 3Health News:pcRUSH.com / Atman, Inc. is Awarded General Services Administration (GSA) Schedule (GS-35F-0099W) 2Health News:Okuma Real Help Machine Tool Giveaway Finalists Announced 2Health News:Study highlights lack of patient knowledge regarding hospital medications 2
Provides a combination of concentrated cold / hot and compression for the back...
... One-Piece™ Collar is completely injected molded from ... our patented chin support. , ,Our ... efficiently managed where space is limited. Color-coded ... of sizes., ,Either in a supine ...
... therapy Gel Pad. Our Gel Pad helps defeat ... reduce swelling and /or hot therapy to increase ... hot and cold therapy gel pad, place an ... can be added to each support upon request. ...
... Because when it comes to superior immobilization ... do the job., ,You already know that ... is immobilization of the c-spine. But what you ... that Jerome Medical's NECLOC ®: provides superior immobilization ...
Medicine Products: